These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16254620)

  • 1. Study of antiparkinsonic activity of panavir on a model of Parkinson syndrome induced by systemic administration of MPTP to outbred rats and C57Bl/6 mice.
    Kalinina TS; Nerobkova LN; Voronina TA; Stovbun SV; Litvin AA; Sergienko VI
    Bull Exp Biol Med; 2005 Jul; 140(1):55-7. PubMed ID: 16254620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease.
    Kreisler A; Duhamel A; Vanbesien-Mailliot C; Destée A; Bordet R
    Behav Pharmacol; 2010 May; 21(3):194-205. PubMed ID: 20440202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.
    Santos DB; Colle D; Moreira EL; Hort MA; Godoi M; Le Douaron G; Braga AL; Assreuy J; Michel PP; Prediger RD; Raisman-Vozari R; Farina M
    Mol Neurobiol; 2017 Mar; 54(2):1513-1530. PubMed ID: 26852411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Anti-Glutamate Antibodies in Modeled Parkinsonian Syndrome.
    Kucheryanu VG; Vetrile LA; Zakharova IA; Voronina NA
    Bull Exp Biol Med; 2020 Aug; 169(4):431-434. PubMed ID: 32889565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
    Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
    Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
    Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
    J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the novel aminoadamantane derivative A-7 on Parkinsonian syndrome induced by systemic administration of neurotoxin MPTP].
    Nerobkova LN; Val'dman EA; Voronina TA; Markina NV; Sharkova LM
    Eksp Klin Farmakol; 2000; 63(3):3-6. PubMed ID: 10934586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
    Choi JG; Huh E; Ju IG; Kim N; Yun J; Oh MS
    J Neurol Sci; 2018 Sep; 392():77-82. PubMed ID: 30031172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson's disease.
    Janakiraman U; Manivasagam T; Justin Thenmozhi A; Dhanalakshmi C; Essa MM; Song BJ; Guillemin GJ
    Physiol Behav; 2017 May; 173():132-143. PubMed ID: 28185878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
    Castro AA; Ghisoni K; Latini A; Quevedo J; Tasca CI; Prediger RD
    Behav Brain Res; 2012 Apr; 229(1):208-15. PubMed ID: 22266923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of complex phytoadaptogen on MPTP-induced Parkinson's syndrome in mice.
    Bocharov EV; Kucheryanu VG; Kryzhanovskii GN; Bocharova OA; Kudrin VS; Belorustseva SA
    Bull Exp Biol Med; 2006 May; 141(5):560-3. PubMed ID: 17181052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Matheus FC; Aguiar AS; Castro AA; Villarinho JG; Ferreira J; Figueiredo CP; Walz R; Santos AR; Tasca CI; Prediger RD
    Behav Brain Res; 2012 Dec; 235(2):263-72. PubMed ID: 22921927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson's disease induced by co-administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate.
    Shimazu S; Takahata K; Tamashiro A; Yoneda F; Iida Y; Saji H
    J Neural Transm (Vienna); 2003 Aug; 110(8):871-83. PubMed ID: 12898343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Doo AR; Kim ST; Kim SN; Moon W; Yin CS; Chae Y; Park HK; Lee H; Park HJ
    Neurol Res; 2010 Feb; 32 Suppl 1():88-91. PubMed ID: 20034453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mexidol potentiates antiparkinsonian effect of L-DOPA in MPTP-induced parkinsonism model].
    Kucherianu VG
    Eksp Klin Farmakol; 2001; 64(1):22-5. PubMed ID: 11544797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profile of acupuncture treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease model.
    Hong MS; Park HK; Yang JS; Park HJ; Kim ST; Kim SN; Park JY; Song JY; Park HK; Jo DJ; Park SW; HwanYun D; Ban JY; Chung JH
    Neurol Res; 2010 Feb; 32 Suppl 1():74-8. PubMed ID: 20034450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect of baicalin on mouse with Parkinson's disease induced by MPTP].
    Chen X; Zhang N; Zou HY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Nov; 27(11):1010-2. PubMed ID: 18173149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
    J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.